Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Benkert

Showing results (61-70 of 135) with videos related to

Pageof 14
Sort By:
International Journal of Molecular Sciences|March 27, 2025
Transient Global Amnesia (TGA): Is It Really Benign? A Pilot Study on Blood BiomarkersFabio Rossini, Tobias Moser, Michael Unterhofer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 15, 2020
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosisMarie-Christine Reinert, Pascal Benkert, Jens Wuerfel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2021
CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating eventManuel Comabella, Margareta A Clarke, Sabine Schaedelin, et al.
Brain : a Journal of Neurology|June 4, 2018
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosisChristian Barro, Pascal Benkert, Giulio Disanto, et al.
European Journal of Neurology|February 13, 2023
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosisArabella Buchmann, Lukas Pirpamer, Daniela Pinter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2025
White Matter Tract Degeneration in Multiple Sclerosis Patients With Progression Independent of Relapse ActivityMario Ocampo-Pineda, Alessandro Cagol, Pascal Benkert, et al.
Critical Care (London, England)|January 21, 2021
Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective studySabina Hunziker, Adrian Quinto, Maja Ramin-Wright, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2021
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosisTomas Uher, Eva Kubala Havrdova, Pascal Benkert, et al.
Journal of Cardiac Failure|November 19, 2013
Heart failure therapy-induced early ST2 changes may offer long-term therapy guidanceTobias Breidthardt, Cathrin Balmelli, Raphael Twerenbold, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 30, 2023
Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomesMelissa Amrein, Stephanie Meier, Ibrahim Schäfer, et al.
Pageof 14

Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|March 27, 2025
Transient Global Amnesia (TGA): Is It Really Benign? A Pilot Study on Blood BiomarkersFabio Rossini, Tobias Moser, Michael Unterhofer, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 15, 2020
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosisMarie-Christine Reinert, Pascal Benkert, Jens Wuerfel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2021
CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating eventManuel Comabella, Margareta A Clarke, Sabine Schaedelin, et al.
Brain : a Journal of Neurology|June 4, 2018
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosisChristian Barro, Pascal Benkert, Giulio Disanto, et al.
European Journal of Neurology|February 13, 2023
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosisArabella Buchmann, Lukas Pirpamer, Daniela Pinter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 16, 2025
White Matter Tract Degeneration in Multiple Sclerosis Patients With Progression Independent of Relapse ActivityMario Ocampo-Pineda, Alessandro Cagol, Pascal Benkert, et al.
Critical Care (London, England)|January 21, 2021
Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective studySabina Hunziker, Adrian Quinto, Maja Ramin-Wright, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 6, 2021
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosisTomas Uher, Eva Kubala Havrdova, Pascal Benkert, et al.
Journal of Cardiac Failure|November 19, 2013
Heart failure therapy-induced early ST2 changes may offer long-term therapy guidanceTobias Breidthardt, Cathrin Balmelli, Raphael Twerenbold, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|January 30, 2023
Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomesMelissa Amrein, Stephanie Meier, Ibrahim Schäfer, et al.
Pageof 14